Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis.
about
A systematic review of aspirin in primary prevention: is it time for a new approach?Low-dose aspirin use does not diminish the immune response to monovalent H1N1 influenza vaccine in older adultsPreventive Aspirin and Other Antiplatelet Medication Use Among U.S. Adults Aged ≥ 40 Years: Data from the National Health and Nutrition Examination Survey, 2011-2012.A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.Aspirin overutilization for the primary prevention of cardiovascular disease.Identifying opportunities to improve aspirin utilization for the primary prevention of cardiovascular disease in a regional health care system.Disparities in heart failure and other cardiovascular diseases among women.Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patientsDifferent time trends by gender for the incidence of Hodgkin's lymphoma among young adults in the USA: a birth cohort phenomenon.Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events.Charting the Future for Ethnicity and Health Research: Clinical and Population Science Insights From the MESA.Patterns of antiplatelet agent use in the US.
P2860
Q26864015-5DE0B356-F298-4BA2-B43E-1545A2CCE305Q30378668-F3DFBECA-024E-4F7C-BF25-9D8C4198F313Q31021374-03A63F9B-3856-480E-A9E7-9EF2D5CDFDCAQ33622632-9DEAA7C6-9387-4A63-B1CB-5045FDFB0D27Q33801854-4DC1B01C-6641-42FA-B122-A6E51F1A00D2Q34657167-D219FA2B-EFDB-4952-904D-70196BFC8BABQ35551012-6994E9EC-DDA5-4AE6-B9A3-4598B36225D5Q36282612-D304F81D-6ADE-4F7B-A87E-F4366FA62DFBQ36379615-AA8596AE-4CF3-4EDB-803B-3682518A1A8BQ36832395-F93DE5F6-5C2A-4FDF-B371-592BEBAF1620Q37187151-EA244071-8C56-4D18-90A6-4907C6303461Q37584843-5BF8EB40-82A6-45B1-9026-A8C3E2C7373DQ38688827-31527284-69BD-4BBD-BB7B-31C7E30AFDAAQ38811606-03AADA6D-19AD-4423-87D7-5FB4C3F8C1CBQ41585393-0060CADC-EAF5-4F56-82EF-3589CE793565
P2860
Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@ast
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@en
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@nl
type
label
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@ast
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@en
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@nl
prefLabel
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@ast
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@en
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@nl
P2093
P2860
P1476
Comparison of the racial/ethni ...... hnic study of atherosclerosis.
@en
P2093
Ana V Diez Roux
Daniel R Sanchez
Erin D Michos
Gregory L Burke
Karol Watson
Pamela J Schreiner
Roger S Blumenthal
P2860
P356
10.1016/J.AMJCARD.2010.08.041
P407
P577
2011-01-01T00:00:00Z